Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.
Blood Adv. 2024 Jun 11;8(11):2967-2979. doi: 10.1182/bloodadvances.2023012008.
Blood Adv. 2024.
PMID: 38315873
CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.
Lauruschkat CD, Muchsin I, Rein A, Erhard F, Grathwohl D, Dölken L, Köchel C, Falk CS, Einsele H, Wurster S, Grigoleit GU, Kraus S.
Lauruschkat CD, et al.
Front Immunol. 2023 May 10;14:1148841. doi: 10.3389/fimmu.2023.1148841. eCollection 2023.
Front Immunol. 2023.
PMID: 37234158
Free PMC article.
Item in Clipboard
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM.
Rein AF, Lauruschkat CD, Muchsin I, Köchel C, Tischer-Zimmermann S, Bauersfeld L, Nelde A, Lübke M, Prusty BK, Schlosser A, Halenius A, Eiz-Vesper B, Dölken L, Grigoleit GU, Einsele H, Erhard F, Kraus S.
Rein AF, et al.
Blood Adv. 2024 Feb 13;8(3):712-724. doi: 10.1182/bloodadvances.2023011120.
Blood Adv. 2024.
PMID: 38127299
Free PMC article.
Item in Clipboard
Cite
Cite